BSGM:NSD-BioSig Technologies, Inc (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 3.70

Change

0.00 (0.00)%

Market Cap

USD 0.13B

Volume

0.15M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-07-24 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALGN Align Technology, Inc

N/A

USD50.51B 110.75 75.87
PODD Insulet Corporation

N/A

USD18.95B 2,177.56 158.14
ABMD Abiomed, Inc

N/A

USD14.90B 66.50 53.94
LVGO Livongo Health, Inc

N/A

USD14.20B N/A N/A
BRKR Bruker Corporation

N/A

USD12.48B 62.34 30.81
TNDM Tandem Diabetes Care, Inc

N/A

USD6.52B N/A N/A
SWAV ShockWave Medical, Inc

N/A

USD6.07B N/A N/A
IART Integra LifeSciences Holdings ..

N/A

USD5.79B 34.37 20.57
INMD InMode Ltd

N/A

USD4.19B 48.60 39.99
LIVN LivaNova PLC

N/A

USD4.05B 77.40 N/A

ETFs Containing BSGM

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.13% 24% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.13% 24% F 27% F
Trailing 12 Months  
Capital Gain -55.42% 4% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -55.42% 4% F 4% F
Trailing 5 Years  
Capital Gain 164.85% 74% C 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 164.85% 74% C 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 66.76% 86% B 89% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 66.76% 86% B 89% B+
Risk Return Profile  
Volatility (Standard Deviation) 115.66% 18% F 13% F
Risk Adjusted Return 57.72% 76% C 75% C
Market Capitalization 0.13B 31% F 23% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 6.32 39% F 24% F
Price / Cash Flow Ratio -4.82 38% F 64% D
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -300.05% 10% F 13% F
Return on Invested Capital -330.30% 5% F 1% F
Return on Assets -162.14% 1% F 0% N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 5.11 36% F 23% F
Short Percent 7.52% 26% F 26% F
Beta 1.72 20% F 21% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector